Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.44% |
AMGEN INC. | AMGN | 5.24% |
GILEAD SCIENCES, INC. | GILD | 4.96% |
VERTEX PHARMACEUTICALS | VRTX | 4.27% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.22% |
REGENERON PHARMACEUTICALS | REGN | 3.14% |
INSMED INC | INSM | 2.57% |
CORTEVA INC | CTVA | 2.47% |
ASTRAZENECA PLC ADR | AZN | 2.15% |
NATERA INC | NTRA | 1.91% |
BIOGEN IDEC, INC. | BIIB | 1.88% |
BEONE MEDICINES LTD-ADR | BGNE | 1.84% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.74% |
INCYTE CORP | INCY | 1.52% |
ILLUMINA INC | ILMN | 1.49% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.48% |
IONIS PHARMACEUTICALS, IN | IONS | 1.43% |
EXACT SCIENCES | EXAS | 1.38% |
CRISPR THERAPEUTICS AG | CRSP | 1.38% |
UNITED THERAPEUTICS CORP | UTHR | 1.38% |
VIATRIS INC | VTRS | 1.38% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.38% |
ARGENX SE - ADR | ARGX | 1.36% |
BRIDGEBIO PHARMA INC | BBIO | 1.32% |
MODERNA INC | MRNA | 1.28% |
EXELIXIS, INC. | EXEL | 1.27% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.26% |
GUARDANT HEALTH INC | GH | 1.23% |
AVIDITY BIOSCIENCES INC | RNA | 1.20% |
ALKERMES PLC | ALKS | 1.20% |
CYTOKINETICS INC | CYTK | 1.17% |
REVOLUTION MEDICINES INC | RVMD | 1.15% |
PROTAGONIST THER | PTGX | 1.15% |
ROIVANT SCIENCES LTD | ROIV | 1.12% |
VAXCYTE INC | PCVX | 1.12% |
BIONTECH SE-ADR | BNTX | 1.06% |
HALOZYME THERAPEUTICS INC | HALO | 1.02% |
CRINETICS PHARMACEUTICALS | CRNX | 1.00% |
INTELLIA THERAPE | NTLA | 0.98% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.97% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.97% |
PTC THERAPEUTICS | PTCT | 0.97% |
TG THERAPEUTICS | TGTX | 0.93% |
AXSOME THERAPEUT | AXSM | 0.92% |
AKERO THERAPEUTICS INC | AKRO | 0.92% |
VIKING THERAPEUTICS INC | VKTX | 0.92% |
NUVALENT INC-A | NUVL | 0.85% |
ADMA BIOLOGICS INC | ADMA | 0.72% |
MEDPACE HOLDINGS | MEDP | 0.72% |
ULTRAGENYX PHARM | RARE | 0.71% |
VERACYTE INC | VCYT | 0.71% |
APELLIS PHARMACE | APLS | 0.70% |
SUMMIT THERAPEUTICS INC | SMMT | 0.69% |
BEAM THERAPEUTICS INC | BEAM | 0.68% |
AMICUS THERAPEUTICS INC | FOLD | 0.67% |
ARCELLX INC | ACLX | 0.66% |
SAREPTA THERAPEU | SRPT | 0.65% |
IDEAYA BIOSCIENCES INC | IDYA | 0.63% |
RECURSION PHARMACEUTICALS | RXRX | 0.62% |
TWIST BIOSCIENCE CORP | TWST | 0.61% |
AGIOS PHARMACEUT | AGIO | 0.60% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.60% |
DYNE THERAPEUTICS INC | DYN | 0.58% |
CELLDEX THERAPEUTICS INC | CLDX | 0.57% |
DENALI THERAPEUT | DNLI | 0.56% |
ASCENDIS PHA-ADR | ASND | 0.54% |
MADRIGAL PHARMAC | MDGL | 0.52% |
SOLENO THERAPEUTICS INC | SLNO | 0.49% |
NOVAVAX INC | NVAX | 0.47% |
IMMUNOVANT INC | IMVT | 0.46% |
DYNAVAX TECHNOLOGY | DVAX | 0.45% |
KRYSTAL BIOTECH INC | KRYS | 0.45% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.19% |
Other (Cash, derivatives and other liabilities) | 0.76% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.